SUNSHINE BIOPHARMA INC. (SBFM) Return on equity 2021–2025
SUNSHINE BIOPHARMA INC. (SBFM) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-25.9%FY2025 · since FY2021: -5875.6% → -25.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -25.9% | -4.1 pp |
| FY2024 | -21.8% | -0.6 pp |
| FY2023 | -21.2% | +102.4 pp |
| FY2022 | -123.7% | +5752.0 pp |
| FY2021 | -5875.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice